The subcutaneous implantable cardioverter-defibrillator. Current trends in clinical practice between guidelines and technology progress
01 Pubblicazione su rivista
Adduci C., Ali H., Francia P., Mantovani R., Palano F., Lupo P., Foresti S., De Ambroggi G., Cappato R.
ISSN: 0953-6205
The subcutaneous implantable cardioverter defibrillator (S-ICD) is a valuable alternative to the conventional trans-venous ICD (TV-ICD) for the prevention of sudden cardiac death (SCD). Prospective registries showed that the S-ICD is safe and effective in treating ventricular tachyarrhythmias in high-risk patients without pacing indications. While in earlier studies patients implanted with S-ICDs were young and mostly affected by channelopathies, contemporary S-ICD cohorts include patients with severely impaired left ventricular function and significant comorbidities. This review focuses on S-ICD evidence-based use and highlights current gaps between guidelines recommendations and real-world clinical practice.